|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/00 |
| (11) | Patento numeris | 3193919 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15842660.1 |
| Europos patento paraiškos padavimo data | 2015-09-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-07-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-04-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/050270 |
| Data | 2015-09-15 |
| (87) | Numeris | WO 2016/044326 |
| Data | 2016-03-24 |
| (30) | Numeris | Data | Šalis |
| 201462050567 P | 2014-09-15 | US |
| (72) |
YU, Cheng-der Tony, TW
HSIEH, Yih Huang, TW
CHEN, I Ju, TW
LEE, Wei-han, TW
WANG, Nan-hsuan, TW
|
| (73) |
OBI Pharma, Inc.,
Room W1907, 19F, 3 Yuan-Qu Street Nanking District, Tapei City, 11503,
TW
|
| (54) | IMMUNOGENIC/THERAPEUTIC GLYCOCONJUGATE COMPOSITIONS AND USES THEREOF |
| IMMUNOGENIC/THERAPEUTIC GLYCOCONJUGATE COMPOSITIONS AND USES THEREOF |